In Q2 FY2026 (ended March 31, 2026), Azenta reported revenue of $144.8 million, up 1.0% year-over-year. Net loss was $160.8 million, a significant decline from the prior year, with diluted EPS of -$3.49. Operating loss was $165.8 million, reflecting a large year-over-year decrease. Cash and equivalents stood at $234.0 million, and total equity was $1.55 billion.
•Revenue increased 1.0% YoY to $144.8 million.
•Net loss widened to $160.8 million from a loss of $47.7 million in the prior year.
•Diluted EPS was -$3.49, down from -$1.04.
•Cash and equivalents totaled $234.0 million with no long-term debt reported.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Azenta provides biological and chemical compound sample exploration and management solutions for the life sciences industry globally. Its business is organized into Sample Management Solutions and Multiomics segments.
The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices Sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes.
The Multiomics segment provides genomic and sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. Founded in 1978 and headquartered in Burlington, Massachusetts, Azenta was formerly known as Brooks Automation, Inc. before rebranding in December 2021.
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry globally. Its business is organized into two segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment offers sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also provides consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and sample analysis services comprising gene sequencing, gene synthesis, and related services. Additionally, Azenta has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space.
Where is Azenta (AZTA) listed and in what currency?
Azenta, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol AZTA. The company's shares are traded in United States Dollars (USD). As a US-based company, its financial reporting and stock trading are conducted in USD, which is the official currency of the United States.
What sector and industry does Azenta (AZTA) operate in?
Azenta, Inc. operates in the Healthcare sector and is classified under the Medical Instruments & Supplies industry. This means the company is involved in the development, manufacturing, and distribution of medical instruments and supplies used in healthcare and life sciences. Specifically, Azenta focuses on providing sample management and multiomics solutions that support research and clinical applications in the life sciences field.
Where is Azenta (AZTA) headquartered and what markets does it serve?
Azenta, Inc. is headquartered in Burlington, Massachusetts, United States. The company serves the global life sciences industry, providing its sample management and multiomics solutions to customers worldwide. Its operations span across various regions, with a focus on supporting biological and chemical compound sample exploration and management for research institutions, pharmaceutical companies, and other organizations involved in life sciences.
How does Azenta (AZTA) make money?
Azenta generates revenue through two main business segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment sells products such as automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices. It also offers sample repository services and consultation services for experimental design and implementation. The Multiomics segment provides genomic and sample analysis services, including gene sequencing and gene synthesis. Additionally, Azenta engages in strategic partnerships, such as with Frontier Space Ltd, to conduct scientific experiments in space, which may open new revenue streams.